YARITZA ROSARIO: Open Payments
NPI 1962424291 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 5 payments from 4 companies in 2025. Trend: 2023 $22 · 2024 $0 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $40 |
| Genentech USA, Inc. | 2 | $36 |
| Cycle Pharmaceuticals Inc | 1 | $15 |
Products named: PONVORY, VYVGART HYTRULO, Ocrevus Zunovo, Bafiertam.
Industry payments across NJ — which companies pay providers there.
